- Home
- INR vs CATX Comparison
INR vs CATX Comparison
Compare INR & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INR
- CATX
- Stock Information
- Founded
- INR 2017
- CATX 1983
- Country
- INR United States
- CATX United States
- Employees
- INR N/A
- CATX N/A
- Industry
- INR
- CATX Medical/Dental Instruments
- Sector
- INR
- CATX Health Care
- Exchange
- INR NYSE
- CATX Nasdaq
- Market Cap
- INR 295.3M
- CATX 239.0M
- IPO Year
- INR 2025
- CATX N/A
- Fundamental
- Price
- INR $15.37
- CATX $3.97
- Analyst Decision
- INR Strong Buy
- CATX Strong Buy
- Analyst Count
- INR 7
- CATX 11
- Target Price
- INR $26.86
- CATX $12.90
- AVG Volume (30 Days)
- INR 431.7K
- CATX 1.3M
- Earning Date
- INR 08-11-2025
- CATX 08-11-2025
- Dividend Yield
- INR N/A
- CATX N/A
- EPS Growth
- INR N/A
- CATX N/A
- EPS
- INR 1.89
- CATX N/A
- Revenue
- INR $293,962,000.00
- CATX $1,471,000.00
- Revenue This Year
- INR $49.00
- CATX N/A
- Revenue Next Year
- INR $16.39
- CATX N/A
- P/E Ratio
- INR $8.08
- CATX N/A
- Revenue Growth
- INR 62.18
- CATX N/A
- 52 Week Low
- INR $13.64
- CATX $1.60
- 52 Week High
- INR $23.00
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- INR N/A
- CATX 61.19
- Support Level
- INR N/A
- CATX $3.33
- Resistance Level
- INR N/A
- CATX $3.69
- Average True Range (ATR)
- INR 0.00
- CATX 0.38
- MACD
- INR 0.00
- CATX 0.01
- Stochastic Oscillator
- INR 0.00
- CATX 64.23
About INR INFINITY NATURAL RESOURCES INC
Infinity Natural Resources Inc is an oil and natural gas exploration and production company. The group focused on developing unconventional reserves in Appalachia. The company is engaged in acquiring, exploring, producing, and developing properties for producing oil, natural gas, and natural gas liquids (NGLs) from underground reservoirs.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.